Breaking News, Promotions & Moves

Aprecia Appoints Chief Scientific Officer

Dr. Matharu brings more than 20 years of industry experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Aprecia, a 3DP Pharmaceutical Company, has appointed Amol Matharu, Ph.D., chief scientific officer. Dr. Matharu will lead the company’s R&D function, the foundation for which is Aprecia’s proprietary ZipDose Technology, the first and only commercially viable 3DP technology platform used in the first FDA-approved 3D-printed drug. Amol Matharu, Ph.D. Dr. Matharu has more than 20 years of industry experience, which includes capability development, product innovati...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters